Increased vascular expression of endothelin-1, with unaltered nitric oxide pathway, in fructose-fed hypertensive rats

2000 ◽  
Vol 50 ◽  
pp. 369-370
Author(s):  
Daeho Lee ◽  
Dongjin Chung ◽  
Minyoung Chung ◽  
Jongun Lee
Metabolism ◽  
2001 ◽  
Vol 50 (1) ◽  
pp. 74-78 ◽  
Author(s):  
Dae Ho Lee ◽  
JongUn Lee ◽  
Dae Gill Kang ◽  
Yun Woong Paek ◽  
Dong Jin Chung ◽  
...  

2001 ◽  
Vol 422 (1-3) ◽  
pp. 149-157 ◽  
Author(s):  
Naohiko Kobayashi ◽  
Yousuke Mori ◽  
Shin-ichiro Mita ◽  
Shigefumi Nakano ◽  
Tsutomu Kobayashi ◽  
...  

1994 ◽  
Vol 3 (3) ◽  
pp. 211-214 ◽  
Author(s):  
K. Özsan ◽  
R. K. Türker ◽  
Z. S. Ercan

Escherichia coliendotoxin (LPS) when infused through the renal artery of the rabbit isolated perfused kidney prepared as constant pressure mode, caused a decrease in flow rate and kidney weight indicating its primary vasoconstrictor effect. This effect was predominant in kidneys from rabbits pretreated with LPS. Endothelin-1 at a concentration of 10−10M and big endothelin-1 at a concentration of 10−8M produced equal vasoconstrictor effects in kidney. Addition of endotheHn converting enzyme inhibitor, phosphoramidon, to the perfusion medium at a concentration of 10−6M caused a reduction in the effects of both LPS and big ET-1 without altering the vasoconstrictor effect of ETol. However, addition of methylene blue (10−5M), a soluble guanylate cyclase inhibitor and NG-nitro-L-arginine-methyl ester (10−6M) to the perfusion medium caused a potentiation in the vasoconstrictor effect of LPS. Indomethacin at a concentration of 10−6M did not alter the effect of LPS. These results were taken as evidence for the participation of endothelin peptides and the L-arginine-nitric oxide pathway in the effect ofLPS in rabbit isolated perfused kidney.


1995 ◽  
Vol 73 (7) ◽  
pp. 1065-1069 ◽  
Author(s):  
Q. Tian ◽  
D. Zhao ◽  
D. Y. Tan ◽  
Y. T. Zhao ◽  
Q. H. Li ◽  
...  

Human adrenomedullin (hADM) is a newly isolated peptide with hypotensive activity in normotensive rats. The objective of this study was to investigate the effect of hADM(13–52) on hypertensive animals. hADM(13–52) induced a dose-dependent decrease in the blood pressure of spontaneously hypertensive rats and renal hypertensive rats. This result suggests that hADM is a novel antihypertensive peptide. In isolated rat aortic arteries, hADM(13–52) produced nitric oxide dependent relaxation and inhibited endothelin 1 and angiotensin II release. These in vitro effects may represent the molecular mechanisms underlying the hypotensive action of hADM in vivo.Key words: human adrenomedullin, nitric oxide, endothelin 1, angiotensin II, hypertension.


1994 ◽  
Vol 23 (6) ◽  
pp. 976 ◽  
Author(s):  
Georg Noll ◽  
Marcel R. Tschudi ◽  
Dragutin Novosel ◽  
Thomas F. Lüscher

2002 ◽  
Vol 39 (3) ◽  
pp. 378-388 ◽  
Author(s):  
Ana M. Briones ◽  
María J. Alonso ◽  
Raquel Hernanz ◽  
Marta Miguel ◽  
Mercedes Salaices

Sign in / Sign up

Export Citation Format

Share Document